Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.